Abstract
Background
This study was done to evaluate the prognostic factors that may affect the survival of patients with recurrent hepatic metastasis after curative resection of gastric cancer.
Methods
We reviewed the medical records of 73 patients with recurrent hepatic metastasis after surgical treatment of gastric cancer from January 1995 to December 2005. Prognostic factors were classified into three groups: primary tumor factors, recurrent hepatic factors, and treatment factors. The prognostic values of these factors were assessed using univariate and multivariate analyses by the log-rank test in the Kaplan-Meier method and Cox’s proportional hazard model.
Results
The overall median survival rate of the 73 study patients was 20.0 months [95% confidence interval (CI) 15.4–24.6 months]. The median survival rate after diagnosis of recurrent hepatic metastasis was 5 months (95% CI 3.5–6.5 months). Univariate analysis showed that the favorable prognostic factors were stage I and II among the primary tumor factors, no extrahepatic metastasis and unilobar distribution among the recurrent hepatic factors, and radiofrequency ablation (RFA) ± chemotherapy among the treatment factors when operative treatment had been excluded. The independent favorable prognostic factors revealed by the multivariate analysis were no extrahepatic metastasis and RFA ± chemotherapy. The median survival rate of patients who had two favorable prognostic factors was 27 months (95% CI 0–66.38 months).
Conclusions
Improvement in the survival rate can be expected with RFA ± chemotherapy for patients with recurrent gastric cancer in the liver without extrahepatic metastasis.
Similar content being viewed by others
References
Koga S, Kawaguchi H, Kishimoto H et al (1980) Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasis. Am J Surg 140:356–359
Sakamoto Y, Ohyama S, Yamamoto J et al (2003) Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133:507–511
Okuyama K, Isono K, Juan IK et al (1985) Evaluation of treatment for gastric cancer with liver metastasis. Cancer 55:2498–2505
Ochiai T, Sasako M, Mizuno S et al (1994) Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81:1175–1178
Miyazaki M, Itoh H, Nakagawa K et al (1997) Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 92:490–493
Okano K, Maeba T, Ishimura K et al (2002) Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235:86–91
Sakamoto Y, Sano T, Shimada K et al (2007) Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 95:534–539
Sobin LH, Wittekind C (eds) (2002) International Union Against Cancer (UICC). TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York
Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425
Koga S, Takebayashi M, Kaibara N et al (1987) Pathological characteristics of gastric cancer that develop hematogenous recurrence, with special reference to the site of recurrence. J Surg Oncol 36:239–242
Maehara Y, Orita H, Okuyama T et al (1992) Predictors of lymph node metastasis in early gastric cancer. Br J Surg 79:245–247
Seto Y, Nagawa H, Muto T (1997) Impact of lymph node metastasis on survival with early gastric cancer. World J Surg 21:186–189
Adachi Y, Oshiro T, Mori M et al (1996) Prediction of early and late recurrence after curative resection for gastric carcinoma. Cancer 77:2445–2448
Yamagata K, Kumagai K (2000) Experimental study of lymphogenous peritoneal cancer dissemination: migration of fluorescent-labelled tumor cells in a rat model of mesenteric lymph vessel obstruction. J Exp Clin Cancer Res 19:211–217
Jiang HC, Liu LX, Piao DX et al (2002) Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 8:624–630
Livraghi T, Solbiati L, Meloni MF et al (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–451
Yamakado K, Nakatsuka A, Takaki H et al (2005) Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer. J Vasc Interv Radiol 16:1747–1751
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, SE., Yang, DH. & Kim, CY. Prognostic Factors for Survival in Patients with Hepatic Recurrence After Curative Resection of Gastric Cancer. World J Surg 33, 1468–1472 (2009). https://doi.org/10.1007/s00268-009-0034-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-0034-2